{
    "eid": "2-s2.0-85091101848",
    "title": "State of the Mind: Growing up with HIV",
    "cover-date": "2020-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Adam W. Bartlett",
        "Phoebe C.M. Williams",
        "Watsamon Jantarabenjakul",
        "Stephen J. Kerr"
    ],
    "citedby-count": 2,
    "ref-count": 133,
    "ref-list": [
        "Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy",
        "Altered structural brain changes and neurocognitive performance in pediatric HIV",
        "Structural brain changes in perinatally HIV-infected young adolescents in South Africa",
        "Cerebral injury in perinatally HIV-infected children compared to matched healthy controls",
        "White matter microstructure among youth with perinatally acquired HIV is associated with disease severity",
        "A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naive \u201cslow progressors",
        "HIV-associated CD4 +/CD8 + depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy",
        "Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents",
        "High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood",
        "Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls",
        "Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial",
        "HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors",
        "Mental health challenges among adolescents living with HIV",
        "Mental health and functional competence in the cape town adolescent antiretroviral cohort",
        "Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium",
        "Psychiatric disorders, antiretroviral medication adherence and viremia in a cohort of perinatally HIV-infected adolescents and young adults",
        "HIV infection and depression",
        "Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth",
        "Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges",
        "Predictors of mental health problems in adolescents living with HIV in Namibia",
        "Psychometric properties of instruments for assessing depression among African youth: a systematic review",
        "The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis",
        "Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study",
        "Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand",
        "Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis",
        "Neurologic manifestations of human immunodeficiency virus infection in children",
        "Neurological and neuropathological features of human immunodeficiency virus infection in children",
        "Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group",
        "Neurological complications in infants and children with acquired immune deficiency syndrome",
        "Early viral suppression improves neurocognitive outcomes in HIV-infected children",
        "Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study",
        "Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy",
        "Early antiretroviral therapy improves neurodevelopmental outcomes in infants",
        "increased risk of executive function and emotional behavioral problems among virologically well-controlled perinatally hiv-infected adolescents in Thailand and Cambodia",
        "Cognition, emotional health, and immunological markers in children with long-term nonprogressive HIV",
        "Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa",
        "HIV-Associated Cognitive Impairment in Perinatally Infected Children: a Meta-analysis",
        "The impact of perinatal HIV infection on older school-aged children\u2019s and adolescents\u2019 receptive language and word recognition skills",
        "A behavioral and cognitive profile of clinically stable HIV-infected children",
        "Health care transition for youth living with HIV/AIDS",
        "Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth",
        "A prospective longitudinal study of mental health symptoms among perinatally HIV-infected and HIV-exposed but uninfected urban youths",
        "The impact of environmental risk factors on HIV-associated cognitive decline in children",
        "Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment",
        "Gender, race and economic perspectives on the social epidemiology of HIV infection: implications for prevention",
        "Neighborhood, family, and subjective socioeconomic status: how do they relate to adolescent health?",
        "Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia",
        "Psychiatric disorders and young adult milestones in HIV-exposed, uninfected youth",
        "Effect of maternal substance abuse on the fetus, neonate, and child",
        "Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age",
        "Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study",
        "Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV",
        "In utero exposure to HIV and/or antiretroviral therapy: a systematic review of preclinical and clinical evidence of cognitive outcomes",
        "Central nervous system viral invasion and inflammation during acute HIV infection",
        "Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis",
        "AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations",
        "Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages",
        "Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)",
        "HIV-1-induced neuronal injury in the developing brain",
        "Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4",
        "Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia",
        "Brain development during childhood and adolescence: a longitudinal MRI study",
        "The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus",
        "Age-dependent neurologic manifestations of HIV infection in childhood",
        "Central nervous system abnormalities in pediatric human immunodeficiency virus infection",
        "Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected Mothers",
        "Default mode connectivity in youth with perinatally acquired HIV",
        "Clinical associations of white matter damage in cART-treated HIV-positive children in South Africa",
        "Regional brain gray and white matter changes in perinatally HIV-infected adolescents",
        "Neuropsychological function and cerebral metabolites in HIV-infected youth",
        "Low risk of neurodevelopmental impairment among perinatally acquired HIV-infected preschool children who received early antiretroviral treatment in Thailand",
        "Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV",
        "Neural correlates of socioeconomic status in the developing human brain",
        "Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART)",
        "Neurodevelopment in perinatally HIV-infected children: a concern for adolescence",
        "Is specific HIV eradication from the brain possible or needed?",
        "Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children",
        "CNS penetration of ART in HIV-infected children",
        "Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA",
        "Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz",
        "Rethinking the risk-benefit ratio of efavirenz in HIV-infected children",
        "Neuropsychiatric and neurocognitive manifestations in hiv-infected children treated with efavirenz in South Africa\u2014a retrospective case series",
        "Efavirenz and the CNS: what we already know and questions that need to be answered",
        "Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity",
        "Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility",
        "Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice",
        "Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system",
        "Neurologic complications of HIV disease and their treatment",
        "Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance",
        "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid",
        "Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders",
        "Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy",
        "Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort",
        "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy",
        "Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy",
        "CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection",
        "CYP2B6 haplotype predicts efavirenz plasma concentration in black South African HIV-1-infected children: a longitudinal pediatric pharmacogenomic study",
        "Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): extended follow-up results of a randomised, open-label, non-inferiority trial",
        "CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana",
        "Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors",
        "Biodegradable nanoparticles for delivery of therapeutics in CNS infection",
        "Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment",
        "Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation",
        "Developmental screening tools: feasibility of use at primary healthcare level in low- and middle-income settings",
        "The International HIV Dementia Scale: a new rapid screening test for HIV dementia",
        "Validity of the international HIV dementia scale in South Africa",
        "Development of a psychosocial distress measure for Ugandan adolescents living with HIV",
        "Prevalence of depression and validation of the Beck Depression Inventory-II and the Children\u2019s Depression Inventory-Short amongst HIV-positive adolescents in Malawi",
        "Development and validation of a 20-item screening scale to detect major depressive disorder among adolescents with HIV in rural Uganda: a mixed-methods study",
        "Mental health in South African adolescents living with HIV",
        "I don\u2019t feel shy because I will be among others who are just like me\u2026\u201d: The role of support groups for children perinatally infected with HIV in Zimbabwe",
        "Building resilience: a mental health intervention for Tanzanian youth living with HIV",
        "Building resilient families: developing family interventions for preventing adolescent depression and HIV in low resource settings",
        "Family-based prevention of mental health problems in children affected by HIV and AIDS: an open trial",
        "Development and implementation of health and wellness CBT for individuals with depression and HIV",
        "Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial",
        "Effective treatment of depressive disorders in medical clinics for adolescents and young adults living with HIV: a controlled trial",
        "Efficacy of cognitive behavioural therapy delivered over the Internet for depressive symptoms: a systematic review and meta-analysis",
        "Internet-assisted cognitive behavioral therapy",
        "Choosing antidepressants for HIV and AIDS patients: insights on safety and side effects",
        "Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach",
        "Antidepressants for depression in adults with HIV infection",
        "Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine",
        "The efficacy of cognitive training programs in children and adolescents: a meta-analysis",
        "A randomized controlled trial to evaluate if computerized cognitive rehabilitation improves neurocognition in Ugandan children with HIV"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60089710",
            "affilname": "The University of Sydney School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60089710",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60015296",
            "affilname": "Sydney Children's Hospital, Randwick",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015296",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}